Monday, September 26, 2016

Mylan's EpiPen Profit 60% Higher Than Told to Congress

Mylan says that the $100 profit per two-pack of its EpiPen injectors presented by CEO Heather Bresch to Congress last week is actually 60% higher.

from WSJ.com: US Business http://ift.tt/2cXbr8P
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)